Corrado Lodigiani

InstitutionHumanitas Research Hospital and University
AddressRozzano
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in May 2020 and November 2020 and February 2021
    All Publications
    Bar chart showing 39 publications over 15 distinct years, with a maximum of 8 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lanza E, Mancuso ME, Messana G, Ferrazzi P, Lisi C, Di Micco P, Barco S, Balzarini L, Lodigiani C. Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients. J Clin Med. 2021 Jun 29; 10(13). PMID: 34209720.
      Citations:    
    2. Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P. Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. J Blood Med. 2021; 12:69-75. PMID: 33603528.
      Citations: 1     
    3. Russo V, Proietti R, Lodigiani C, Di Micco P. Fondaparinux and bleeding risk in COVID-19: unsolved question. Thromb Res. 2021 04; 200:128-129. PMID: 33592530.
      Citations: 1     Fields:    Translation:Humans
    4. Di Micco P, Russo V, Carannante N, Imparato M, Cardillo G, Lodigiani C. Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study. J Clin Med. 2020 Dec 21; 9(12). PMID: 33371524.
      Citations: 9     
    5. Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Castaldo G, Di Micco P. Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study. Front Med (Lausanne). 2020; 7:569567. PMID: 33330530.
      Citations: 5     
    6. Valerio L, Ferrazzi P, Sacco C, Ruf W, Kucher N, Konstantinides SV, Barco S, Lodigiani C. Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients. Thromb Haemost. 2021 01; 121(1):98-101. PMID: 33212544.
      Citations: 5     Fields:    Translation:Humans
    7. Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Di Micco P. Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience. J Cardiovasc Pharmacol. 2020 10; 76(4):369-371. PMID: 33027192.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    8. Di Micco P, Russo V, Lodigiani C. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate. Medicina (Kaunas). 2020 Sep 27; 56(10). PMID: 32992511.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    9. Russo V, Di Maio M, Attena E, Silverio A, Scudiero F, Celentani D, Lodigiani C, Di Micco P. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study. Pharmacol Res. 2020 09; 159:104965. PMID: 32474087.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    10. Di Micco P, Russo V, Carannante N, Imparato M, Rodolfi S, Cardillo G, Lodigiani C. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort. J Clin Med. 2020 May 07; 9(5). PMID: 32392741.
      Citations: 31     
    11. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020 07; 191:9-14. PMID: 32353746.
      Citations: 695     Fields:    Translation:HumansPHPublic Health
    Lodigiani's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (95)
    Explore
    _
    Co-Authors (62)
    Explore
    _
    Similar People (60)
    Explore
    _